161 related articles for article (PubMed ID: 31451379)
21. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
[TBL] [Abstract][Full Text] [Related]
22. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
[TBL] [Abstract][Full Text] [Related]
23. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
[TBL] [Abstract][Full Text] [Related]
24. Post-transplantation lymphoproliferative disorders (PTLD) localized in the central nervous system: report from an international survey on PTLD.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):235-42. PubMed ID: 23538344
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus associated post-transplant Hodgkin lymphoma in an adult patient after cord blood stem cell transplantation for acute lymphoblastic leukemia.
Okuno K; Horie Y; Kanai K; Kato M; Kuwamoto S; Okazaki T; Hayashi K
J Clin Exp Hematop; 2009 May; 49(1):45-51. PubMed ID: 19474517
[TBL] [Abstract][Full Text] [Related]
27. Post-transplant lymphoproliferative disorder--case reports of three children with kidney transplant.
Spasojević-Dimitrijeva B; Peco-Antić A; Paripović D; Kruscić D; Krstić Z; Cupić M; Cvetković M; Milosevski-Lomić G; Kostić M
Srp Arh Celok Lek; 2014; 142(1-2):83-8. PubMed ID: 24684038
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
Swinnen LJ
J Natl Cancer Inst Monogr; 2001; (28):38-43. PubMed ID: 11158205
[TBL] [Abstract][Full Text] [Related]
29. Post-transplant lymphoproliferative disorders (PTLD) after renal transplantation: management and evolution of seven cases among 1002 renal transplants in São Paulo, Brazil.
Colleoni GW; Oliveira JS; Borducchi DM; Fernandes MA; Da Silva HT; Alves AC; De Franco MF; Kerbauy J; Pestana JO
Leuk Lymphoma; 2000 Sep; 39(1-2):145-50. PubMed ID: 10975393
[TBL] [Abstract][Full Text] [Related]
30. EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.
Xu H; Rewerska J; Aardsma N; Slavin K; Valyi-Nagy T; Ni H
Folia Neuropathol; 2017; 55(3):221-226. PubMed ID: 28984115
[TBL] [Abstract][Full Text] [Related]
31. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
32. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
[TBL] [Abstract][Full Text] [Related]
33. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
34. Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall.
Mohri T; Ikura Y; Hirakoso A; Okamoto M; Hishizawa M; Takaori-Kondo A; Kato S; Nakamura S; Yoshimura K; Okabe H; Iwai Y
Int J Hematol; 2018 Aug; 108(2):218-227. PubMed ID: 29380181
[TBL] [Abstract][Full Text] [Related]
35. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
36. Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
Karuturi M; Shah N; Frank D; Fasan O; Reshef R; Ahya VN; Bromberg M; Faust T; Goral S; Schuster SJ; Stadtmauer EA; Tsai DE
Transpl Int; 2013 Jun; 26(6):616-22. PubMed ID: 23551167
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review.
Ziarkiewicz-Wróblewska B; Górnicka B; Gierej B; Suleiman W; Nowacka-Cieciura E; Durlik M; Bogdańska M; Wasiutyński A; Pileri SA
Pol J Pathol; 2008; 59(1):63-9. PubMed ID: 18655373
[TBL] [Abstract][Full Text] [Related]
38. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.
Soler MJ; Puig JM; Mir M; Parrilla J; Pedro C; Salar A; Serrano S; Lloveras J
Transplant Proc; 2003 Aug; 35(5):1709-13. PubMed ID: 12962767
[TBL] [Abstract][Full Text] [Related]
39. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
40. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
